"aurobindo-pharma"

Hyderabad-based Aurobindo says buyback will reward shareholders, boost returns, improve earnings per share, without changing control or affecting management structure

Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received a Notice of Compliance from Health Canada for its biosimilar Dyrupeg, used to treat cancer patients with low neutrophil levels, following a successful regulatory review

The drug major continues to see healthy demand across key markets, with US and Europe businesses performing in line with expectations, said its Vice-Chairman and Managing Director K Nithyananda Reddy

Aurobindo Pharma said a fire at its subsidiary APL Healthcare’s Unit-IV in Naidupeta, Andhra Pradesh, temporarily disrupted production. Two lines were impacted, causing a 3 per cent hit to monthly capacity. The blaze was swiftly controlled, with no casualties reported.

The company has declared an interim dividend of Rs 4 per equity share, to be paid on or before August 21

Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and middle-income markets

US-based unit of the drug major is recalling Acetaminophen Tablets (325 mg) in the US due to cGMP (Current Good Manufacturing Practices) deviations

Nishka Agarwal of Telangana clinched gold in the women’s all-round individual championship (artistic) in the on-going Khelo India Youth Games in Patna on Tuesday

The company temporarily suspends operations at the Penicillin-G production facility in Kakinada, Andhra Pradesh

Under the agreements, MSN Laboratory will establish a manufacturing unit along with a Research & Development (R&D) center. Laurus Labs and Aurobindo Pharma will set up formulation units. Gland Pharma has shown interest in opening an R&D center, as well as manufacturing units for injectables and drug substances. Dr. Reddy's Labs plans to establish a unit for injectables and biosimilars. Hetero Labs will set up a plant for finished dose and injectable manufacturing.

Topping the Hyderabad billionaires in the Forbes roster is Murali Divi and family, securing the 33rd spot with a staggering net worth of $6.3 billion.

At the end of the inspection, a Form 483 was issued with one observation which is procedural in nature, it added.

Telangana government in collaboration with Aurobindo Pharma on Sunday inaugurated the high-end cancer care block at MNJ Cancer Hospital.

Aurobindo Pharma Foundation (APF) inaugurated and dedicated Vedasadanam Block to Sri Sankara Gurukula Veda Patasala located in Shameerpet, Medchal–Malkajgiri district

They were arrested under Prevention of Money Laundering Act following day-long questioning with them here at the Enforcement Directorate headquarters on Wednesday.

Hyderabad: Aurobindo Pharma said on Monday that it has acquired the domestic formulation business of Veritaz Healthcare on a slump sale basis. The transaction was agreed at a consideration of Rs 171 crore on a debt-free cash-free basis. The transaction comes into effect from April 1 and is expected to close by May 2022. This […]

Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]

Hyderabad: To ensure quality tertiary cancer care facilities are available for free of cost to needy patients, the Telangana government in collaboration with voluntary organisations is developing crucial medical infrastructure at city-based MNJ Cancer Hospital with a cost of over Rs. 95 crore. As part of these efforts, on Friday, which also coincides with World […]

New Delhi: Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (active pharmaceutical ingredient) manufacturing facility. The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a […]

This is the first oral antiviral approved by India, the UK agency, and also by the US Foods & Drugs Administration.